繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Jaguar Health Awarded Patent in Jordan for Short Bowel Syndrome Treatment

2024-08-27 22:58

10:58 AM EDT, 08/27/2024 (MT Newswires) -- Jaguar Health (JAGX) said Tuesday its Napo Pharmaceuticals unit received a patent in Jordan for its crofelemer antidiarrheal drug.

The patent covers methods for treating short bowel syndrome, bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal in patients with an inhibitor of chloride-ion transport such as crofelemer, a plant-based prescription medicine, Jaguar said.

Shares of Jaguar Health were down more than 1% in recent trading.

Price: 1.16, Change: -0.01, Percent Change: -1.28

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。